IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report

Ryotaro Yoneoka; Hajime Kasai; Aoi Hino; Ayumi Hayashi; Atsushi Sasaki; Masayuki Ota; Katsuhiko Asanuma; Takuji Suzuki

doi:10.12659/AJCR.941826

28 December 2023 : Case report Japan

IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report

Rare coexistence of disease or pathology

Ryotaro Yoneoka^1ABCDEF, Hajime Kasai^234ABCDEF*, Aoi Hino^2ABCDE, Ayumi Hayashi^5BCDE, Atsushi Sasaki^2BCDE, Masayuki Ota^6BCDE, Katsuhiko Asanuma^5DE, Takuji Suzuki^2DE

DOI: 10.12659/AJCR.941826

Am J Case Rep 2023; 24:e941826

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 5. Kidney biopsy specimens demonstrated numerous proliferations of the mesangial areas and endocapillary proliferation, stained with (A) periodic acid-Schiff (×300) and (B) periodic acid-methenamine silver. Immunofluorescent studies revealed deposition of (C) immunoglobulin A and (E) C3, without (D) immunoglobulin M, in superficial blood vessels (×400).

Back to the Article

IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report

Your Privacy